MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosis

Magnetic Resonance Imaging

Volumn 28, Issue 2, 2010, Pages 163-170

  Srinivasan, Radhika ^a   Ratiney, Helene ^b   Hammond Rosenbluth, Kathyrn E ^a   Pelletier, Daniel ^c   Nelson, Sarah J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

7T; Glutathione; MR Spectroscopy; Multiple sclerosis; Oxidative stress

Indexed keywords

GLUTATHIONE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GRAY MATTER; HISTOCHEMISTRY; HUMAN; IMAGE ANALYSIS; IN VIVO STUDY; MOLECULAR PROBE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE STRESS; PRIORITY JOURNAL; SCINTISCANNING; SENSITIVITY ANALYSIS; SIGNAL DETECTION; WHITE MATTER;

EID: 77349125827     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2009.06.008     Document Type: Article

References (35)

1. Terpstra M., Henry P.G., Gruetter R. Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference-edited spectra. Magn Reson Med 2003, 50(1):19-23.
2. Otazo R., Mueller B., Ugurbil K., Wald L., Posse S. Signal-to-noise ratio and spectral linewidth improvements between 1.5 and 7 Tesla in proton echo-planar spectroscopic imaging. Magn Reson Med 2006.
3. Srinivasan R., Vigneron D., Napapon S., Hurd R., Nelson S. A comparative study of myo-inositol quantification using LCmodel at 1.5T and 3.0T with 3D 1H proton spectroscopic imaging of the human brain. MRI 2004, 51(3):435-446.
4. Tkac I., Oz G., Gruetter R. Comparison of metabolite quantification in the human brain at 4 and 7 Tesla. Proceedings for the International Society of Magnetic Resonance in Medicine 2005, 2458. [Miami].
5. Dringen R., Hirrlinger J. Glutathione pathways in the brain. Biol Chem 2003, 384(4):505-516.
6. Hayes J.D., Strange R.C. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000, 61(3):154-166.
7. Mann C.L., Davies M.B., Boggild M.D., Alldersea J., Fryer A.A., Jones P.W., et al. Glutathione S-transferase polymorphisms in MS: their relationship to disability. Neurology 2000, 54(3):552-557.
8. Tajouri L., Mellick A.S., Ashton K.J., Tannenberg A.E., Nagra R.M., Tourtellotte W.W., et al. Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis. Brain Res Mol Brain Res 2003, 119(2):170-183.
9. Frade J., Pope S., Schmidt M., Dringen R., Barbosa R., Pocock J., et al. Glutamate induces release of glutathione from cultured rat astrocytes - a possible neuroprotective mechanism?. J Neurochem 2008.
10. Starlack J., Nelson S., Kurhanewicz J., Huang L.R., Vigneron D. Improved water and Lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn Reson Med 1997, 38(2):311-321.
11. Hammond K., Lupo J., Kelley D., Nelson S. Comparison of the B0 field and shimming in human brains at 3T and 7T. Proceedings for the International Society of Magnetic Resonance in Medicine 2006, 2352. [Seattle].
12. Stollberger R., Wach P. Imaging of the active B1 field in vivo. Magn Reson Med 1996, 35(2):246-251.
13. Pauly J., Le Roux P., Nishimura D., Macovski A. Parameter relations for Shinnar-Le Roux selective excitation pulse design algorithm. IEEE Trans Med Imaging 1991, 10:56-65.
14. Moonen C., Van Zijl P. Highly effective water suppression for in-vivo. J Magn Reson 1990, 88:28-41.
15. Nelson S.J. Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors. Magn Reson Med 2001, 46(2):228-239.
16. Osorio J.A., Ozturk-Isik E., Xu D., Cha S., Chang S., Berger M.S., et al. 3D 1H MRSI of brain tumors at 3.0 Tesla using an eight-channel phased-array head coil. J Magn Reson Imaging 2007, 26(1):23-30.
17. Pruessmann K.P., Weiger M., Scheidegger M.B., Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn Reson Med 1999, 42(5):952-962.
18. Pijnappel W.W.F., Boogaart Vd., Beer R.D., Ormondt D.V. SVD-based quantification of magnetic resonance signals. JMagn Reson 1992, 97:122-134.
19. Smith S. Fast robust automated brain extraction. Hum Brain Mapp 2002, 17:143-155.
20. Zhang Y., Brady M., Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 2001, 20:45-57.
21. Hetherington H.P., Pan J.W., Mason G.F., Adams D., Vaughn M.J., Twieg D.B., et al. Quantitative 1H spectroscopic imaging of human brain at 4.1 T using image segmentation. Magn Reson Med 1996, 36(1):21-29.
22. Snyder J., Thompson R.B., Wild J.M., Wilman A.H. Strongly coupled versus uncoupled spin response to radio frequency interference effects: application to glutamate and glutamine in spectroscopic imaging. NMR Biomed 2007, 21(4):402-409.
23. Garwood M., DelaBarre L. The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. J Magn Reson 2001, 153:155-177.
24. McNab J.A., Bartha R. Quantitative short echo-time 1H LASER-CSI in human brain at 4 T. NMR Biomed 2006, 19(8):999-1009.
25. Wright P.J., Mougin O.E., Totman J.J., Peters A.M., Brookes M.J., Coxon R., et al. (1) measurements in brain tissue at 7, 3, and 1.5T using IR-EPI, IR-TSE, and MPRAGE: results and optimization. Magma 2008, 21(1-2):121-130.
26. Srinivasan R., Cunningham C., Chen A., Vigneron D., Hurd R., Nelson S., et al. TE-averaged two- dimensional proton spectroscopic imaging of glutamate at 3 T. Neuroimage 2006, 30(4):1171-1178.
27. Cooper A. Role of astrocytes in maintaining cerebral glutathione homeostasis and in protecting the brain against xenobiotics and oxidative stress. Glutathione in the nervous system 1998, 91-115. Taylor and Francis, London. C.A. Shaw (Ed.).
28. Sasaki T., Senda M. Evaluation of glutathione localization in brain using 99mTc meso-HMPAO. J Nucl Med 1999, 40(6):1056-1060.
29. Bongarzone E.R., Pasquini J.M., Soto E.F. Oxidative damage to proteins and lipids of CNS myelin produced by in vitro generated reactive oxygen species. J Neurosci Res 1995, 41(2):213-221.
30. Merrill J.E., Ignarro L.J., Sherman M.P., Melinek J., Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993, 151(4):2132-2141.
31. Lu F., Selak M., O'Connor J., Croul S., Lorenzana C., Butunoi C., et al. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci 2000, 177(2):95-103.
32. Kidd D., Barkhof F., McConnell R., Algra P.R., Allen I.V., Revesz T. Cortical lesions in multiple sclerosis. Brain 1999, 122(Pt 1):17-26.
33. Chard D.T., Griffin C.M., Parker G.J., Kapoor R., Thompson A.J., Miller D.H. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 2002, 125(Pt 2):327-337.
34. Audoin B., Davies G.R., Finisku L., Chard D.T., Thompson A.J., Miller D.H. Localization of grey matter atrophy in early RRMS: a longitudinal study. J Neurol 2006, 253(11):1495-1501.
35. Mohamed A., Shoker A., Bendjelloul F., Mare A., Alzrigh M., Benghuzzi H., et al. Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor. Biomed Sci Instrum 2003, 39:440-445.